 |
|
|
| |
DACLATASVIR COMBINED WITH PEGINTERFERON ALFA-2A AND RIBAVIRIN FOR 12 OR 16 WEEKS IN PATIENTS WITH HEPATITIS C VIRUS GENOTYPE 2 OR 3 INFECTION: COMMAND GT 2/3 STUDY
|
| |
| |
Reported by Jules Levin
IDSA Oct 2-6 2013 San Francisco, CA
Dore GJ, Lawitz E, Hezode C, Shafran S, Ramji A, Tatum H, Taliani G, Tran A, Brunetto M, Zaltron S, Strasser S, Weis N, Ghesquiere W, Lee S, Larrey D, Pol S, Harley H, George J, Fung S, de Lédinghen V, Hagens P, Cohen D, Cooney E, Noviello S, Hughes EA
|
| |
|
|
|
|
|
